Minaris Launches AgentSCREEN Adventitious Virus Detection by NGS to Simplify Viral Safety Testing for Cell Banks and Cell-Based Samples
PR Newswire —
GMP-qualified NGS adventitious virus detection with a predictable 28-day turnaround and U.S.-based end-to-end support PHILADELPHIA, March 4, 2026 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality...